{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:46:42Z","timestamp":1792691202072,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.mayocp.2019.06.012","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T08:11:38Z","timestamp":1571818298000},"page":"2427-2436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use"],"prefix":"10.1016","volume":"94","author":[{"given":"Marco","family":"Proietti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marzona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Fortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Merlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Mannuccio","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carla","family":"Roncaglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.mayocp.2019.06.012_bib1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.012_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.mayocp.2019.06.012_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejim.2018.05.016","article-title":"Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: a comparison between EORP-AF pilot and EHS-AF registries","volume":"55","author":"Proietti","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.012_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0895-4356(97)00306-5","article-title":"Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases","volume":"51","author":"van den Akker","year":"1998","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"9836","key":"10.1016\/j.mayocp.2019.06.012_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"issue":"7313","key":"10.1016\/j.mayocp.2019.06.012_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.323.7313.625","article-title":"Complexity science: the challenge of complexity in health care","volume":"323","author":"Plsek","year":"2001","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.mayocp.2019.06.012_bib7","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2018.03.022","article-title":"Multimorbidity in older adults with cardiovascular disease","volume":"71","author":"Forman","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.012_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.012_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ehjqcco\/qcw025","article-title":"Impact of co-morbid burden on mortality in patients with coronary heart disease, heart failure, and cerebrovascular accident: a systematic review and meta-analysis","volume":"3","author":"Rashid","year":"2016","journal-title":"Eur Hear J Qual Care Clin Outcomes"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.012_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.mayocp.2019.06.012_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2019.02.006","article-title":"Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: an ancillary analysis from the RE-DUAL PCI trial","volume":"212","author":"Lip","year":"2019","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.mayocp.2019.06.012_bib12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","article-title":"Practical considerations on the use of the Charlson comorbidity index with administrative data bases","volume":"49","author":"D\u2019Hoore","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.012_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/heartjnl-2017-311546","article-title":"Atrial fibrillation prevention: an appraisal of current evidence","volume":"104","author":"Boriani","year":"2018","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.mayocp.2019.06.012_bib14","first-page":"190","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.012_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: A report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.mayocp.2019.06.012_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jamacardio.2017.4665","article-title":"Association of atrial fibrillation clinical phenotypes with treatment patterns and outcomes: a multicenter registry study","volume":"3","author":"Inohara","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.mayocp.2019.06.012_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12872-016-0235-1","article-title":"Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study","volume":"16","author":"Vanbeselaere","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"FI_3","key":"10.1016\/j.mayocp.2019.06.012_bib18","doi-asserted-by":"crossref","first-page":"f329","DOI":"10.1093\/europace\/eux322","article-title":"Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings\u00a0from UK Biobank cohort","volume":"20","author":"Jani","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.mayocp.2019.06.012_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2017.03.024","article-title":"Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)","volume":"189","author":"Steinberg","year":"2017","journal-title":"Am Heart J"},{"issue":"20","key":"10.1016\/j.mayocp.2019.06.012_bib20","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.mayocp.2019.06.012_bib21","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.amjmed.2016.06.045","article-title":"Causes of death and influencing factors in patients with atrial fibrillation","volume":"129","author":"Fauchier","year":"2016","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.012_bib22","first-page":"e00297","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.012_bib23","first-page":"722","article-title":"\u201cReal-world\u201d atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase","volume":"19","author":"Proietti","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.mayocp.2019.06.012_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2018.05.034","volume":"271","author":"Boriani","year":"2018","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.06.012_bib25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.amjcard.2017.11.028","article-title":"ACTIVE A Steering Committee and Investigators. Predictors of mortality in patients with atrial fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])","volume":"121","author":"Perera","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mayocp.2019.06.012_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ahj.2016.03.023","article-title":"Atrial fibrillation without comorbidities: prevalence, incidence, and prognosis (from the Framingham Heart Study)","volume":"177","author":"Kim","year":"2016","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.mayocp.2019.06.012_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/heartjnl-2013-304588","article-title":"Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012","volume":"100","author":"Radovanovic","year":"2014","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.mayocp.2019.06.012_bib28","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/01.STR.0000135225.80898.1c","article-title":"Charlson index comorbidity adjustment for ischemic stroke outcome studies","volume":"35","author":"Goldstein","year":"2004","journal-title":"Stroke"},{"issue":"24","key":"10.1016\/j.mayocp.2019.06.012_bib29","first-page":"1947","article-title":"Integrated care in atrial fibrillation: a systematic review and meta-analysis","volume":"103","author":"Gallagher","year":"2017","journal-title":"Heart"},{"issue":"10105","key":"10.1016\/j.mayocp.2019.06.012_bib30","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(17)31072-3","article-title":"The future of atrial fibrillation management: integrated care and stratified therapy","volume":"390","author":"Kirchhof","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.012_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/europace\/eux318","article-title":"Integrating new approaches to atrial fibrillation management: The 6th AFNET\/EHRA Consensus Conference","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.012_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to\u00a0improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.012_bib33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.amjmed.2018.06.012","article-title":"Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) pathway","volume":"131","author":"Proietti","year":"2018","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2019.06.012_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nrcardio.2016.42","article-title":"Big data analytics to improve cardiovascular care: promise and challenges","volume":"13","author":"Rumsfeld","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.06.012_bib35","doi-asserted-by":"crossref","first-page":"e0188482","DOI":"10.1371\/journal.pone.0188482","article-title":"The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: a systematic review and meta-regression analysis","volume":"12","author":"Vestergaard","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mayocp.2019.06.012_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity. a critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J\u00a0Clin Epidemiol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619306287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619306287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:27:26Z","timestamp":1577813246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619306287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0025619619306287"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.06.012","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}